Voltage-gated Calcium Channels Provide an Alternate Route for Iron Uptake in Neuronal Cell Cultures

Overview

Journal Neurochem Res

Specialties Chemistry
Neurology

Date 2007 Apr 4

PMID 17404834

Citations 25

Authors

Julie A Gaasch

Werner J Geldenhuys

Paul R Lockman

David D Allen

Cornelis J Van der Schyf

Affiliations

Soon will be listed here.

Abstract

Recent studies suggest that iron enters cardiomyocytes via the L-type voltage-gated calcium channel (VGCC). The neuronal VGCC may also provide iron entry. As with calcium, extraneous iron is associated with the pathology and progression of neurodegenerative diseases such as Parkinson's and Alzheimer's disease. VGCCs, ubiquitously expressed, may be an important route of excessive entry for both iron and calcium, contributing to cell toxicity or death. We evaluated the uptake of (45)Ca(2+) and (55)Fe(2+) into NGF-treated rat PC12, and murine N-2alpha cells. Iron not only competed with calcium for entry into these cells, but iron uptake (similar to calcium uptake) was inhibited by nimodipine, a specific L-type VGCC blocker, and enhanced by FPL 64176, an L-VGCC activator, in a dose-dependent manner. Taken together, these data suggest that voltage-gated calcium channels are an alternate route for iron entry into neuronal cells under conditions that promote cellular iron overload toxicity.

Citing Articles

Effect of calcium-channel blockers on the risk of active tuberculosis and mortality: systematic review and meta-analysis.

Meregildo-Rodriguez E, Asmat-Rubio M, Bardales-Zuta V, Vasquez-Tirado G Front Pharmacol. 2024; 15:1298919.

PMID: 38303987 PMC: 10830796. DOI: 10.3389/fphar.2024.1298919.

Iron and Targeted Iron Therapy in Alzheimer's Disease.

Wang J, Fu J, Zhao Y, Liu Q, Yan X, Su J Int J Mol Sci. 2023; 24(22).

PMID: 38003544 PMC: 10671546. DOI: 10.3390/ijms242216353.

Iron homeostasis imbalance and ferroptosis in brain diseases.

Long H, Zhu W, Wei L, Zhao J MedComm (2020). 2023; 4(4):e298.

PMID: 37377861 PMC: 10292684. DOI: 10.1002/mco2.298.

Synaptic Activity Regulates Mitochondrial Iron Metabolism to Enhance Neuronal Bioenergetics.

Tena-Morraja P, Rique-Pujol G, Muller-Sanchez C, Reina M, Martinez-Estrada O, Soriano F Int J Mol Sci. 2023; 24(2).

PMID: 36674431 PMC: 9864932. DOI: 10.3390/ijms24020922.

COVID-19, Cation Dysmetabolism, Sialic Acid, CD147, ACE2, Viroporins, Hepcidin and Ferroptosis: A Possible Unifying Hypothesis.

Cavezzi A, Menicagli R, Troiani E, Corrao S F1000Res. 2022; 11:102.

PMID: 35340277 PMC: 8921693. DOI: 10.12688/f1000research.108667.2.

References

McDonough S, Mori Y, Bean B . FPL 64176 modification of Ca(V)1.2 L-type calcium channels: dissociation of effects on ionic current and gating current. Biophys J. 2004; 88(1):211-23. PMC: 1304999. DOI: 10.1529/biophysj.104.051714. View

SCRIABINE A, van den Kerckhoff W . Pharmacology of nimodipine. A review. Ann N Y Acad Sci. 1988; 522:698-706. DOI: 10.1111/j.1749-6632.1988.tb33415.x. View

Crowe S, Bartfay W . Amlodipine decreases iron uptake and oxygen free radical production in the heart of chronically iron overloaded mice. Biol Res Nurs. 2002; 3(4):189-97. DOI: 10.1177/109980040200300404. View

Mwanjewe J, Hui B, Coughlin M, Grover A . Treatment of PC12 cells with nerve growth factor increases iron uptake. Biochem J. 2001; 357(Pt 3):881-6. PMC: 1222020. DOI: 10.1042/0264-6021:3570881. View

Aisen P, Wessling-Resnick M, Leibold E . Iron metabolism. Curr Opin Chem Biol. 1999; 3(2):200-6. DOI: 10.1016/S1367-5931(99)80033-7. View

Umbreit J, CONRAD M, Moore E, Latour L . Iron absorption and cellular transport: the mobilferrin/paraferritin paradigm. Semin Hematol. 1998; 35(1):13-26. View

Sofic E, Riederer P, Heinsen H, Beckmann H, Reynolds G, Hebenstreit G . Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J Neural Transm. 1988; 74(3):199-205. DOI: 10.1007/BF01244786. View

Rampe D, Dage R . Functional interactions between two Ca2+ channel activators, (S)-Bay K 8644 and FPL 64176, in smooth muscle. Mol Pharmacol. 1992; 41(4):599-602. View

Bishop G, Robinson S, Liu Q, Perry G, Atwood C, Smith M . Iron: a pathological mediator of Alzheimer disease?. Dev Neurosci. 2002; 24(2-3):184-7. DOI: 10.1159/000065696. View

10.

Tsushima R, Wickenden A, Bouchard R, Oudit G, Liu P, Backx P . Modulation of iron uptake in heart by L-type Ca2+ channel modifiers: possible implications in iron overload. Circ Res. 1999; 84(11):1302-9. DOI: 10.1161/01.res.84.11.1302. View

11.

Zheng W, Rampe D, Triggle D . Pharmacological, radioligand binding, and electrophysiological characteristics of FPL 64176, a novel nondihydropyridine Ca2+ channel activator, in cardiac and vascular preparations. Mol Pharmacol. 1991; 40(5):734-41. View

12.

Yagami T, Ueda K, Sakaeda T, Itoh N, Sakaguchi G, Okamura N . Protective effects of a selective L-type voltage-sensitive calcium channel blocker, S-312-d, on neuronal cell death. Biochem Pharmacol. 2004; 67(6):1153-65. DOI: 10.1016/j.bcp.2003.11.005. View

13.

Connor J, Menzies S, St Martin S, Mufson E . Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains. J Neurosci Res. 1990; 27(4):595-611. DOI: 10.1002/jnr.490270421. View

14.

Bradbury M . Transport of iron in the blood-brain-cerebrospinal fluid system. J Neurochem. 1997; 69(2):443-54. DOI: 10.1046/j.1471-4159.1997.69020443.x. View

15.

Kunze D, Rampe D . Characterization of the effects of a new Ca2+ channel activator, FPL 64176, in GH3 cells. Mol Pharmacol. 1992; 42(4):666-70. View

16.

Connor J, Menzies S, Burdo J, Boyer P . Iron and iron management proteins in neurobiology. Pediatr Neurol. 2001; 25(2):118-29. DOI: 10.1016/s0887-8994(01)00303-4. View

17.

Moos T, Morgan E . The metabolism of neuronal iron and its pathogenic role in neurological disease: review. Ann N Y Acad Sci. 2004; 1012:14-26. DOI: 10.1196/annals.1306.002. View

18.

Castellani R, Smith M, Nunomura A, Harris P, Perry G . Is increased redox-active iron in Alzheimer disease a failure of the copper-binding protein ceruloplasmin?. Free Radic Biol Med. 1999; 26(11-12):1508-12. DOI: 10.1016/s0891-5849(99)00016-7. View

19.

Kissel K, Hamm S, Schulz M, Vecchi A, Garlanda C, Engelhardt B . Immunohistochemical localization of the murine transferrin receptor (TfR) on blood-tissue barriers using a novel anti-TfR monoclonal antibody. Histochem Cell Biol. 1998; 110(1):63-72. DOI: 10.1007/s004180050266. View

20.

Usowicz M, Porzig H, Becker C, Reuter H . Differential expression by nerve growth factor of two types of Ca2+ channels in rat phaeochromocytoma cell lines. J Physiol. 1990; 426:95-116. PMC: 1189878. DOI: 10.1113/jphysiol.1990.sp018128. View